Increased Thoracic Fluid as the Most Distinctive Cardiovascular Hemodynamic Alteration in Men with Prolactinoma.
Agnieszka JurekPaweł KrzesińkiGrzegorz GielerakPrzemysław WitekGrzegorz ZielińskiAnna KazimierczakRobert WierzbowskiMałgorzata BanakBeata Uziębło-ŻyczkowskaPublished in: Nutrients (2022)
Hyperprolactinemia in males with prolactin-secreting adenomas, or prolactinomas, may be associated with endothelial dysfunction and co-existing cardiovascular risk factors. As a noninvasive technique of assessing cardiac function, impedance cardiography (ICG) may be useful in the early detection of hemodynamic dysfunction. The aim of the present study was to analyze and compare the hemodynamic profiles of patients with prolactinoma versus controls. A total of 20 men with prolactinoma (PR group) (mean age 43 years) and 20 men from the control group (CG) were evaluated in this prospective, observational comparative clinical study. The study subjects were propensity score-matched in terms of clinical characteristics-age, mean blood pressure [MBP], arterial hypertension [AH] rates, and body mass index [BMI]. ICG assessments of hemodynamic profiles were conducted with the use of a Niccomo ™ device and included stroke volume index (SI), cardiac index (CI), systemic vascular resistance index (SVRI), velocity index (VI), acceleration index (ACI), Heather index (HI), and thoracic fluid content (TFC). AH was well-controlled in both study groups (116/76 mmHg PR vs. 119/76 mmHg CG). In comparison with CG patients, ICG revealed PR group patients to have higher rates of high thoracic fluid content (TFC) (>35 1/kOhm; p = 0.035) and lower SI values (<35 mL/m 2 , p = 0.072). There was a convergent tendency towards lower values of other cardiac function parameters (SI, CI, VI, ACI, and HI). Prolactinoma-associated endocrine abnormalities are related to hemodynamic profile alterations, including higher rates of increased TFC and the risk of worsened cardiac function.
Keyphrases
- body mass index
- end stage renal disease
- blood pressure
- cardiovascular risk factors
- chronic kidney disease
- newly diagnosed
- ejection fraction
- spinal cord
- prognostic factors
- oxidative stress
- metabolic syndrome
- fluorescence imaging
- patient reported outcomes
- clinical trial
- heart failure
- adipose tissue
- magnetic resonance imaging
- type diabetes
- weight gain
- physical activity
- single cell
- left ventricular
- cross sectional
- weight loss
- ionic liquid
- insulin resistance
- cerebral ischemia
- blood glucose